EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target

Allison B Reiss iD, Saba Ahmed, Maryann Johnson, Usman Saeedullah iD, Joshua De Leon

Metabolites · 27.03.2023 · 13 (4) · 479

DOI: 10.3390/metabo13040479 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 27.03.2023. Verfasst von Allison B Reiss und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USA. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 275 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally. In recent decades, clinical research has made significant advances, resulting in improved survival and recovery rates for patients with CVD. Despite this progress, there is substantial residual CVD risk and an unmet need for better treatment. The complex and multifaceted pathophysiological mechanisms underlying the development of CVD pose a challenge for researchers seeking effective therapeutic interventions. Consequently, exosomes have emerged as a new focus for CVD research because their role as intercellular communicators gives them the potential to act as noninvasive diagnostic biomarkers and therapeutic nanocarriers. In the heart and vasculature, cell types such as cardiomyocytes, endothelial cells, vascular smooth muscle, cardiac fibroblasts, inflammatory cells, and resident stem cells are involved in cardiac homeostasis via the release of exosomes. Exosomes encapsulate cell-type specific miRNAs, and this miRNA content fluctuates in response to the pathophysiological setting of the heart, indicating that the pathways affected by these differentially expressed miRNAs may be targets for new treatments. This review discusses a number of miRNAs and the evidence that supports their clinical relevance in CVD. The latest technologies in applying exosomal vesicles as cargo delivery vehicles for gene therapy, tissue regeneration, and cell repair are described.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosiscardiovascular diseasecholesterolexosomemicroRNAoligonucleotide

Autor:innen und Institutionen

  • Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USA.

ORCID-Profile: Allison B Reiss, Usman Saeedullah

Zitieren

APA

Reiss, A. B., Ahmed, S., Johnson, M., Saeedullah, U., & De Leon, J. (2023). Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target. Metabolites, 13(4), 479. https://doi.org/10.3390/metabo13040479

Vancouver

Reiss AB, Ahmed S, Johnson M, Saeedullah U, De Leon J. Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target. Metabolites. 2023;13(4):479. doi:10.3390/metabo13040479

BibTeX
@article{Reiss2023,
  author = {Reiss, Allison B and Ahmed, Saba and Johnson, Maryann and Saeedullah, Usman and De Leon, Joshua},
  title = {Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target},
  journal = {Metabolites},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {479},
  doi = {10.3390/metabo13040479}
}
Kostenlos starten →